“This disappointing news confirms the complexity of treating Alzheimer’s disease and the need to further advance knowledge in neuroscience." https://twitter.com/statnews/status/1108693834471493632?s=19

The question is: who advances that knowledge in neuroscience? Pharma has scaled back its neuro spending by 70% over the last 15 years. Academic disease research is generally small scale and low risk. Who is institutionally positioned to take big swings at disease?